Table 1.
Univariate and multivariate analysis of overall survival (Cox regression model)
| Characteristics | Total (N) |
Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) |
P-value | Hazard ratio (95% CI) |
P-value | ||
|
T stage (T3 and T4 vs. T1 and T2) |
145 |
1.312 (0.756–2.277) |
0.334 | ||
|
N stage (N1 and N2 and N3 vs. N0) |
144 |
2.970 (1.606–5.493) |
< 0.001 |
2.173 (0.954–4.946) |
0.064 |
|
M stage (M1 vs. M0) |
129 |
5.075 (2.312–11.136) |
< 0.001 |
2.515 (1.083–5.838) |
0.032 |
|
Gender (Male vs. Female) |
162 |
2.306 (0.922–5.770) |
0.074 |
1.957 (0.573–6.689) |
0.284 |
|
Age (> 60 vs. ≤ 60) |
162 |
0.831 (0.506–1.365) |
0.466 | ||
|
Pathologic stage (III and IV vs. I and II) |
142 |
3.223 (1.807–5.747) |
< 0.001 |
1.788 (0.810–3.947) |
0.151 |
|
Histological type (Adenocarcinoma vs. squamous cell carcinoma) |
162 |
0.875 (0.526–1.455) |
0.607 | ||
|
β3GNT2 (High vs. low) |
162 |
1.736 (1.041–2.897) |
0.035 |
1.537 (0.839–2.815) |
0.043 |